Morgan Stanley Nuvasive Inc Transaction History

Morgan Stanley

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.71 - $44.15 $12.5 Million - $15 Million	-340,330 Reduced 33.65%	670,948 $27.9 Million
Q1 2023 May 15, 2023	BUY	$36.81 - $48.12 $23.2 Million - $30.3 Million	629,104 Added 164.61%	1,011,278 $41.8 Million
Q4 2022 Feb 14, 2023	SELL	$35.68 - $44.71 $2.1 Million - $2.64 Million	-58,996 Reduced 13.37%	382,174 $15.8 Million
Q3 2022 Nov 14, 2022	SELL	$42.51 - $54.02 $17.5 Million - $22.2 Million	-411,323 Reduced 48.25%	441,170 $19.3 Million
Q2 2022 Oct 27, 2022	BUY	$46.84 - $59.75 $13.8 Million - $17.6 Million	295,119 Added 52.95%	852,493 $41.9 Million
Q2 2022 Aug 15, 2022	BUY	$46.84 - $59.75 $13.8 Million - $17.6 Million	295,119 Added 52.95%	852,493 $41.9 Million
Q1 2022 Oct 27, 2022	SELL	$48.09 - $57.79 $14.2 Million - $17.1 Million	-295,119 Reduced 34.62%	557,374 $31.6 Million
Q1 2022 May 13, 2022	BUY	$48.09 - $57.79 $8.32 Million - $9.99 Million	172,943 Added 44.99%	557,374 $31.6 Million
Q4 2021 Feb 14, 2022	SELL	$47.19 - $62.68 $1.04 Million - $1.38 Million	-22,061 Reduced 5.43%	384,431 $20.2 Million
Q3 2021 Nov 15, 2021	BUY	$56.91 - $67.81 $23.1 Million - $27.6 Million	406,492 New	406,492 $24.3 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.